|
Ruiz de Angulo D, Munitiz V, Ortiz MÁ, Martínez de Haro LF, Frutos MD, Hernández A, Parrilla P. Communication between the obese patient and bariatric surgeon. Cir Esp. 2015 Oct;93(8):492-5. doi: 10.1016/j.ciresp.2015.01.006. English, Spanish. PubMed PMID: 25912163.
AÑO: 2015; IF: 1.0
|
25912163
|
Febrero B, Ruiz de Angulo D, Ortiz MÁ, López MJ, Parrilla P. Primary adenocarcinoma of the navel: an uncommon entity. Cir Esp. 2014 Jun-Jul;92(6):436-8. doi: 10.1016/j.ciresp.2012.06.002. English, Spanish. PubMed PMID: 23031719.
AÑO: 2014; IF: 0.743
|
|
Ruiz de Angulo D, Ortiz MÁ, Martínez de Haro LF. Side effects of proton-pump inhibitors: another reason to indicate anti-reflux surgery for Barrett's esophagus? Cir Esp. 2014 May;92(5):303-4. doi: 10.1016/j.ciresp.2014.01.009. PubMed PMID: 24625629.
AÑO: 2014; IF: 0.743
|
|
Revilla-Nuin B, Parrilla P, Lozano JJ, de Haro LF, Ortiz A, Martínez C, Munitiz V, de Angulo DR, Bermejo J, Molina J, Cayuela ML, Yélamos J. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study. Ann Surg. 2013 May;257(5):886-93. doi: 10.1097/SLA.0b013e31826ddba6. PubMed PMID: 23059500.
AÑO: 2013; IF: 7.188
|
|
Martinez de Haro LF, Ortiz A, Parrilla P, Munitiz V, Martinez CM, Revilla B, Ruiz de Angulo D, Bermejo J, Yélamos J, Molina J. Long-term follow-up of malignancy biomarkers in patients with Barrett's esophagus undergoing medical or surgical treatment. Ann Surg. 2012 May;255(5):916-21. doi: 10.1097/SLA.0b013e31824e6c6a. PubMed PMID: 22415421.
AÑO: 2012; IF: 6.329
|